Home › Trial NCT01994031
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
- Trial IDNCT01994031
- StatusUnknown
- PhasePhase 4
- Study typeInterventional
- SponsorNanjing Luye Sike Pharmaceutical Co., Ltd.
- Enrollment36
- Start date2014-08
- ConditionsSolid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.